Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 15 August 2024, 17:00 HKT/SGT
Share:
    

Source: Genes Tech Group Holdings Co Ltd
Genes Tech Group Announces 2024 Interim Results
- Total revenue reached approximately NTD535.01 million
- Total comprehensive income attributable to owners approximately NTD31.30 million
- Revenue from turnkey solutions reached approximately NTD226.60 million
- Basic earnings per share were NTD3.87 cents

HONG KONG, Aug 14, 2024 - (ACN Newswire) - Genes Tech Group Holdings Co. Ltd (“Genes Tech Group” or “The Group”; Stock Code: 8257.HK) announces its interim results for the six months ended 30 June, 2024 (“the period”). During the period, the Group recorded the total revenue of approximately NTD535.01 million, Total comprehensive income for the period attributable to owners of the Company amounted to approximately NTD31.30 million. Basic earnings per share were NTD3.87 cents.

During the period, revenue from turnkey solutions amounted to approximately NTD226.60 million, accounting for approximately 42.35% of the Group’s total revenue. The revenue from trading of parts and used SME amounted to approximately NTD308.41 million, accounting for approximately 57.65% of the Group’s total revenue. During the period under review, under the ongoing geopolitical tensions, the Group deepened cooperation with existing international clients and continually explored new areas and models of collaboration. The Group's revenue from operation in Japan significantly increased by 7,038.01% compared with last year, representing approximately 9.79% of the Group's total revenue, while revenue from operation in the United States increased by 15.54% from last year, representing approximately 23.70% of the Group's total revenue.

In the first half of 2024, the rise of generative artificial intelligence (AI) technology has provided significant growth impetus for demand on chips and memory. However, the uncertainties of the global economic environment, along with the slowdown in the growth of the industrial and automotive sectors, leading to a slower-than-expected pace of recovery for the entire semiconductor industry. According to the data recently released by the Semiconductor Industry Association (SIA), the monthly sales of the global semiconductor industry have achieved year-on-year growth since 2024. In May, sales reached USD49.1 billion, with an annual growth rate of 19.3% and a monthly growth rate of 4.1%. Such annual growth rate was the highest since April 2022, showcasing the vigorous development trend of generative AI applications, which brought a strong growth momentum to the semiconductor industry.

Mr. Yang Ming-Hsiang, Chairman and Chief Executive Officer concluded: “With the rapid development of AI technology, the market is entering a new era fully empowered by AI. This transformation not only deeply reconstructs industry ecosystems but also opens unprecedented golden opportunities for the semiconductor industry. The robust demand for AI and high-performance computing data centers is driving chip manufacturers to establish closer collaborations with memory, packaging and testing companies, working together to build a strong ecosystem, thus enhancing the overall competitiveness of the entire industry chain. However, the complex geopolitical landscape continues to have profound effects on the global semiconductor industry, especially in AI, which is a core area of Sino-US competition. The Group will adopt a cautious strategy, flexibly adapting to market changes and seizing development opportunities. At the same time, the Group will also strive to achieve breakthroughs in key technologies to solidify our market position in intense competition, aiming to create long-term and sustainable value returns for the shareholders.”

About Genes Tech Group Holdings Co Ltd (Stock Code: 8257.HK)

Genes Tech Group Holdings Co. Ltd is a turnkey solution provider and exporter of parts and used SME in Taiwan. Since the commencement of its business in 2009, the Group mainly engaged in providing turnkey solution for parts and used SME for its customers and modifying and/or upgrading the semiconductor equipment of its production systems according to customers needs. In addition, the Group is also engaged in the trading of SEM and parts. The SME and parts supplied by the Group included furnaces, clean tracks and other related items, which were used at the front-end of the semiconductor manufacturing process, wafer fabrication such as deposition, photoresist coating and development, and these were extensively applied in mobile phones, game consoles, DVD players, automotive sensors and other digital electronic products. Visit https://www.genestech.com/en/.

Press release distributed by Vitalink Consultants for Genes Tech Group Holdings Co. Ltd.
For enquiries, please contact:

Ms. Natural Lau   T: +852 2529 7999   E: Natural.lau@vitalink.com.hk

 




Topic: Earnings
Source: Genes Tech Group Holdings Co Ltd

Sectors: Daily Finance
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management  
Sept 17, 2024 20:30 HKT/SGT
Discover Exclusive Italian-Made Luxury Products at FIND - Design Fair Asia 2024  
Sept 17, 2024 20:00 HKT/SGT
AI Essentials For Small Businesses to Drive Growth and Save Time  
Sept 17, 2024 17:20 HKT/SGT
JCB and Azer Turk Bank launch JCB merchant acquiring operations across the Republic of Azerbaijan  
Tuesday, September 17, 2024 4:00:00 PM
Fuji frustration for TOYOTA GAZOO Racing  
Tuesday, September 17, 2024 2:01:00 PM
Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner  
Sept 17, 2024 13:30 HKT/SGT
Aryn Hala Announces Launch of Sustainable Cooking Cookbook, Available October 1st  
Sept 17, 2024 11:20 HKT/SGT
Japan International Aerospace Exhibition 2024: Japan's largest comprehensive aerospace industry exhibition  
Tuesday, September 17, 2024 11:00:00 AM
Midea Group Heads For Global Expansion with its ToB Business  
Sept 17, 2024 10:03 HKT/SGT
LENVIMA(R) (lenvatinib) Plus KEYTRUDA(R) (pembrolizumab) in Combination With Transarterial Chemoembolization (TACE) Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)  
Tuesday, September 17, 2024 9:08:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: